Description

Details
Date:

November 22

Time:

07:00 pm - 08:30 pm

Event Category:

PPP

Click to Register: https://www.eventbrite.co.uk/e/ppp-evening-discussion-sir-john-bell-life-sciences-industrial-strategy-tickets-51550417687
Organizer

Public Policy Projects

Website: https://www.eventbrite.co.uk/o/public-policy-projects-15396065294
Venue

Deloitte, the Auditorium, One New Street Square, London, EC4A 3HQ

Public Policy Projects (PPP) in collaboration with deloitte is pleased to invite you to our last life sciences series thought leadership event  of 2018 with Joint Chair of the Life Sciences Industrial Strategy Implementation Board, Professor Sir John Bell GBE “The Implementation of the Life Sciences Industrial Strategy and Sector Deal“.

Following the publication of the UK Life Sciences Industrial Strategy and the first Sector Deal, Sir John will be giving his insight and anlysis on the impact of the strategy and deal as well as offer his thoughts on future development plans for the strategy.  In a workshop style, this event will enable attendees to assess current plans and offer their thoughts for future iterations.

Date: Thursday, November 22nd 2018

Time: 7pm – 9pm

Location: Deloitte, the Auditorium, One New Street Square, London, EC4A 3HQ

Sir John Bell

Sir John is a Canadian immunologist and geneticist.  From 2006 to 2011, he was President of the Academy of Medical Sciences, and since 2002 has held the Regius Chair of Medicine at the University of Oxford.  He was knighted for services to medicine in the New Year Honours of 2009 and appointed Knight Grand Cross of the Order of the British Empire (GBE) in the 2015 New Year Honours for services to medicine, medical research and the life science industry.  He is one of the few Canadians to be admitted to the highest class in this order.

Some of his positions include chairing the board of trustees of the Oxford Health Alliance and the science committee of the UK Biobank he chairs the Global Health Scientific Advisory Board of the Bill and Melinda Gates Foundation, he is a non-executive member of Genomics England, a member of Cancer Research UK.  Sir John has advised governments and foundations in Singapore, France, Canada, Sweden, Finland, Alberta on Biomedical Research.

About Life Sciences and Health Care at Deloitte
We reshape Life Sciences and Health care organisations, making them more efficient, innovative and successful for the patients that need them. Whether we’re integrating new technologies, using data to improve treatments, or supporting regulatory change, we are the trusted advisory and delivery partner for the Life Sciences and Health Care sector.

This discussion will be followed by a reception.  Please let us know of any dietary requirements.

Please RSVP by Friday 16 November using the link or for any questions please email Managing Director Ben Howlett at ben.howlett@policyprojects.com or call 020 7839 9305.

Invitations are strictly by invitation only and non-transferrable.

  • 22 Nov, 2018 19:00 - 20:30 BST
  • Deloitte, the Auditorium, One New Street Square, London, EC4A 3HQ See map

Integrated Care Journal
  • Phone: 0207 8399305
  • ISSN: 2517-2662